Vanina de Verneuil

Executive

Directeur Juridique

Insider activity · 24 months0 buys10 salesCumulative net flow

Dec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 2 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 2 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 3 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 2 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (13 ops.)

€404k

Latest filing published 04 Nov 2026 for Vir Biotechnology, Inc., €14k.

Filing timeline

BuySale

Vanina de Verneuil

Insider track record

Disclosed buys

Disclosed sells

Signal history

Vanina de Verneuil: trading record in brief

Vanina de Verneuil is a declared insider of Vir Biotechnology, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 15 filings, for trades running from 1 November 2024 to 3 November 2026.

No open-market purchase appears, only 13 sales worth €404k. Besides market trades, the filings include 2 share grants. In 2026 alone, the filings show no purchases and 5 sales.

On 4 November 2026 came the latest disclosure, an open-market sale for €14k in Vir Biotechnology, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Vanina de Verneuil

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Vir Biotechnology, Inc. (US)

Declarations15 total

▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives2 Nov 2026Vir Biotechnology, Inc.
15,222 USD0SEC
1,343 shares@ US$11.334Common StockSEC:0001628280-26-070025:0
▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives3 Nov 2026Vir Biotechnology, Inc.
26,718 USD0SEC
2,407 shares@ US$11.10Common StockSEC:0001628280-26-070025:1
▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives25 Feb 2026Vir Biotechnology, Inc.
134,534 USD32SEC
13,700 shares@ US$9.8231.2% of flowCommon StockSEC:0001628280-26-012393:1
▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives24 Feb 2026Vir Biotechnology, Inc.
29,713 USD31SEC
3,117 shares@ US$9.53260.0018% mcap16.0% of flowCommon StockSEC:0001628280-26-012393:0
▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives23 Feb 2026Vir Biotechnology, Inc.
33,115 USD30SEC
4,445 shares@ US$7.457.6% of flowCommon StockSEC:0001628280-26-011328:1
◆
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives22 Feb 2026Vir Biotechnology, Inc.
0SEC
55,000 shares0Common StockSEC:0001628280-26-011328:0
▼
Vanina de Verneuil
EVP, General Counsel, Corp SecExecutives5 Nov 2025Vir Biotechnology, Inc.
12,307 USD27SEC
2,385 shares@ US$5.166.8% of flowCommon StockSEC:0001628280-25-050592:0
▼
Vanina de Verneuil
EVP and General CounselExecutives3 Nov 2025Vir Biotechnology, Inc.
8,003 USD26SEC
1,365 shares@ US$5.8634.4% of flowCommon StockSEC:0001628280-25-049159:0
▼
Vanina de Verneuil
EVP and General CounselExecutives26 Feb 2025Vir Biotechnology, Inc.
67,402 USD33SEC
7,373 shares@ US$9.141840.7% of flowCommon StockSEC:0001628280-25-008499:0
▼
Vanina de Verneuil
EVP and General CounselExecutives24 Feb 2025Vir Biotechnology, Inc.
48,573 USD30SEC
5,140 shares@ US$9.4512.7% of flowCommon StockSEC:0001628280-25-007690:1
◆
Vanina de Verneuil
EVP and General CounselExecutives22 Feb 2025Vir Biotechnology, Inc.
0SEC
35,000 shares0Common StockSEC:0001628280-25-007690:0
▼
Vanina de Verneuil
EVP and General CounselExecutives2 Dec 2024Vir Biotechnology, Inc.
625 USD11SEC
76 shares@ US$8.22010.4% of flowCommon StockSEC:0001628280-24-049897:0
▼
Vanina de Verneuil
EVP and General CounselExecutives6 Nov 2024Vir Biotechnology, Inc.
44,454 USD14SEC
4,397 shares@ US$10.1125.8% of flowCommon StockSEC:0001628280-24-046462:0
▼
Vanina de Verneuil
EVP and General CounselExecutives5 Nov 2024Vir Biotechnology, Inc.
22,226 USD12SEC
2,347 shares@ US$9.475.6% of flowCommon StockSEC:0001628280-24-045387:1
▼
Vanina de Verneuil
EVP and General CounselExecutives1 Nov 2024Vir Biotechnology, Inc.
10,107 USD12SEC
1,403 shares@ US$7.20395.9% of flowCommon StockSEC:0001628280-24-045387:0

15 of 15 declarations

Vanina de Verneuil

Insider track record

Vanina de Verneuil: trading record in brief

Companies and markets linked to Vanina de Verneuil

Similar companies

Related executives